Navigation Links
Bio/Pharmaceutical Contract Manufacturing - Industry Analysis of Dose Manufacturing by the Numbers: Composition, Size, Market Shares, Profitability and Outlook
Date:9/4/2013

Fairfax, VA (PRWEB) September 04, 2013

In their latest Special Report, PharmSouce experts present an important expert analysis of the bio/pharmaceutical contract dose manufacturing industry. Founded on the industry’s most comprehensive database of the dose CMO industry (PharmSource’s STRATEGIC ADVANTAGE Database of Contract Service Providers), this analysis is driven by the organization's proprietary model of the dose manufacturing industry which is continuously updated and refined. The model and assumptions are fully explained so readers can understand how the analysis and conclusions were established.

The report characterizes the bio/pharmaceutical contract dose manufacturing industry along a number of quantitative dimensions, including number and type of participants, market size, market shares of the top CMOs and profitability, and provides PharmSource’s expert outlook for the industry.

For purposes of this report, the contract dose manufacturing universe includes companies that actively promote themselves as contract manufacturers (CMOs) and produce client formulations for pharmaceuticals supplied to the highly regulated markets in North America, Europe and Japan. The contract dose manufacturing universe is defined by 195 companies headquartered primarily in North America, Europe, Japan and India.

This 27-page report includes an Executive Summary, and chapters on Industry Composition and Size, CMO Market Shares, and CMO Profitability, and concludes with a chapter on What it Means, which further assesses the implications of the conclusions for the dose CMO industry. In addition, appendices on methodology and a listing of companies included in the CMO universe as defined are included.

Who should read and study this report? The expertise and skilled analysis in this report gives important insight not available in any other source. This report is required reading for each of the following professionals: 1) CMO executives and strategic decision-makers, who will find it to be an indispensable resource for understanding the industry and a critical input for strategic planning efforts; 2) Sourcing and procurement executives in bio/pharmaceutical companies who seek insights for supplier selection and management, who will find the report a critical resource for understanding crucial components of the supply base; 3) Private equity investors, who will gain an important deeper understanding of the market and indispensable insight for identifying potential investment targets; and 4) Anyone needing a deeper understanding of the bio/pharmaceutical contract dose manufacturing market.

For a limited time, PharmSource is offering a complimentary test-drive and a 15% annual discount on PharmSource STRATEGIC ADVANTAGE online service to qualified companies (new subscribers only). For more information, contact PharmSource's Customer Service Department at +1-703-383-4903,ext. 101 / info(at)pharmsource(dot)com.

About PharmSource

PharmSource Information Services, Inc. is a respected provider of business intelligence on contract drug development and manufacture. PharmSource assists Biotechnology and Pharmaceutical companies in implementing and managing sourcing strategies and programs. They also provide business development products and services to companies that serve the biotechnology and pharmaceutical industries. Since 1996, organizations involved in contract Pharma services have continuously relied on PharmSource publications, databases, surveys and consulting services to provide timely, accurate information and analysis. Visit PharmSource on the web at http://www.pharmsource.com or contact them at +1-703-383-4903 (USA, eastern time-zone).

Read the full story at http://www.prweb.com/releases/2013/9/prweb11062965.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. PharmSource CMO-CDMO Database Expands Coverage to Include Approved Pharmaceutical Products: Intelligence Resource for Analyzing Bio/Pharmaceutical Contract Manufacturing
2. Pharma Contract Manufacturing, Research & Packaging Market a New Report Available at ReportsnReports.com
3. Indiana University Contracts with Virtify for Clinical Trial Disclosure Solutions
4. Fortune 500 Company Contracts with Wireless Analytics to Extend Wireless Expense Management & Mobility Management Services Internationally
5. Boehringer Laboratories LLC Awarded HPG Contract for Clinical Suction Regulators
6. Clinical Development, Contracts and Outsourcing in MENA & APAC, New Webinar Hosted by Xtalks
7. ChanTest Develops New Cardiotoxicity and Contractility Assay with Human Stem Cell Cardiomyocytes
8. Non-Intrusive Rust Remover Gives Out New Set of Samples to Rust Contractors, My Cleaning Products Says the Spray Cuts $1,000s of Rust Removal Expense
9. BioConvergence® Celebrates Seventh Anniversary as a Life Sciences Contract Service Provider
10. Pfenex Inc. Awards Glide Pharma Development Contract for a Solid Formulation of Recombinant Anthrax Vaccine
11. Sterilization Market (Medical Devices, Pharmaceutical, Healthcare, Food Applications), Equipments & Contract Services - Global Forecast To 2017
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... 2016 , ... STACS DNA Inc., the sample tracking software company, today announced ... has joined STACS DNA as a Field Application Specialist. , “I am thrilled ... COO of STACS DNA. “In further expanding our capacity as a scientific integrator, Hays ...
(Date:6/23/2016)... BEACH, Calif. , June 23, 2016  Blueprint ... new biological discoveries to the medical community, has closed ... co-founder Matthew Nunez . "We have ... us with the capital we need to meet our ... will essentially provide us the runway to complete validation ...
(Date:6/23/2016)... ... 23, 2016 , ... ClinCapture, the only free validated electronic ... showcase its product’s latest features from June 26 to June 30, 2016 for ... Disrupting Clinical Trials in The Cloud during the conference. DIA (Drug Information ...
(Date:6/23/2016)... SAN FRANCISCO , June 22, 2016  Amgen ... platinum sponsorship of the QB3@953 life sciences ... improve human health. The shared laboratory space at QB3@953 ... startups overcome a key obstacle for many early stage ... As part of the sponsorship, Amgen launched two "Amgen ...
Breaking Biology Technology:
(Date:4/13/2016)... 13, 2016  IMPOWER physicians supporting Medicaid patients in ... new clinical standard in telehealth thanks to a new ... higi platform, IMPOWER patients can routinely track key health ... mass index, and, when they opt in, share them ... to a local retail location at no cost. By ...
(Date:3/29/2016)... , March 29, 2016 ... "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased to ... ink used in a variety of writing instruments, ensuring ... of originally created collectibles from athletes on LegacyXChange will ... analysis of the DNA. Bill Bollander ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):